Epistra and Hitachi leverage AI to achieve one of the world’s largest yields and up to a 73% reduction in lab experiment iterations in the production of “(S)-Reticuline,” a pharmaceutical intermediate from Fermelanta
Epistra and Hitachi leverage AI to achieve one of the world’s largest yields and up…





